Form 8-K - Current report:
SEC Accession No. 0001789769-23-000100
Filing Date
2023-12-08
Accepted
2023-12-08 17:00:31
Documents
15
Period of Report
2023-12-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20231207.htm   iXBRL 8-K 35381
2 EX-3.1 instilbioincdedeptofstat.htm EX-3.1 951
6 instilbioincdedeptofstat001.jpg GRAPHIC 299023
7 instilbioincdedeptofstat002.jpg GRAPHIC 35339
  Complete submission text file 0001789769-23-000100.txt   633121

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20231207.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20231207_lab.xml EX-101.LAB 25834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20231207_pre.xml EX-101.PRE 13573
9 EXTRACTED XBRL INSTANCE DOCUMENT til-20231207_htm.xml XML 3180
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 231476207
SIC: 2836 Biological Products, (No Diagnostic Substances)